Antagonism of glucocorticoid induction of Epstein-Barr virus early antigens by different steroids in Daudi lymphoma cells
- 31 January 1986
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 24 (1), 417-421
- https://doi.org/10.1016/0022-4731(86)90093-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- RU486, A Progestin and Glucocorticoid Antagonist, Inhibits the Growth of Breast Cancer Cells via the Progesterone Receptor*Journal of Clinical Endocrinology & Metabolism, 1985
- An approach to the mechanism of the potent antiglucocorticoid: 17β-hydroxy- 11β -4-dimethylaminophenyl-17α- propynyl-estra-4,9-dien-3-oneThe Journal of Steroid Biochemistry and Molecular Biology, 1984
- RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activationJournal of Steroid Biochemistry, 1984
- Antagonism of glucocorticoid action in cultured hepatoma cellsJournal of Steroid Biochemistry, 1984
- Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptorExperimental Cell Research, 1983
- Induction of epstein-barr virus early antigens by corticosteroids: Inhibition by TPA and retinoic acidInternational Journal of Cancer, 1983
- Epstein-Barr virus induction by a serum factor I. Induction and cooperation with additional inducersVirology, 1982
- Relation of steroid structure to enzyme induction in hepatoma tissue culture cellsJournal of Molecular Biology, 1970
- RELATION BETWEEN EPSTEIN-BARR VIRAL AND CELL MEMBRANE IMMUNOFLUORESCENCE OF BURKITT TUMOR CELLSThe Journal of Experimental Medicine, 1968
- Immunofluorescence in Cells Derived from Burkitt's LymphomaJournal of Bacteriology, 1966